background image
Health & Nurturing 2016 October/November
Pg 9 - The Sunshine Express
aware of symptoms while they are asleep,¡±
says Dr. Satish Garg of the University of
Colorado Denver, Barbara Davis Center for
Childhood Diabetes.
SmartGuard technology, the latest
advancement developed by Medtronic, is
helping to combat this problem and reduce
lows*. Available in the Medtronic MiniMed
insulin pump systems with continuous
glucose monitoring (CGM), SmartGuard
technology is the only feature available in
the U.S. that takes action against lows*.
Continued delivery of insulin, which is
designed to lower blood sugar levels, when
the person with diabetes is already trend-
ing low could lead to severe hypoglycemia.
SmartGuard technology is designed to
pause insulin delivery if the user¡¯s glucose
levels go below a pre-set limit and isn¡¯t
responding to the system¡¯s alarms.
A study published in the New England
Journal of Medicine demonstrated that
SmartGuard technology not only reduces
the number of low* events per week by a
third but also shortens the length/intensity
of those events at night by 37.5 percent
without increasing A1C** (a measure of
average blood sugar levels over three
months).[2]
¡°The ability to automate the suspension of
insulin is an important feature, particularly
at night, as prolonged hypoglycemia could
be life-threatening,¡± Dr. Garg says.
than 1,000 people with diabetes, and include a
new, user-friendly pump design that is
waterproof***, has the ability to administer
extra doses (boluses) of insulin remotely, and
features a high-definition, full-color screen that
supports easy navigation and enables increased
customization with more intuitive menus.
To learn more about the MiniMed 630G system
and insulin pump therapy, visit http://www.
medtronicdiabetes.com/products/minimed-630g-
insulin-pump-system.
IMPORTANT SAFETY INFORMATION: MiniMed
630G system requires a prescription and should
only be used under direction of a qualified
healthcare professional familiar with the risks
associated with the use of the system. Please
visit www.medtronicdiabetes.com/isi for detailed
safety information including warnings for auto-
matic Suspend on Low feature.
Kaplan has been using an insulin pump - an
externally-worn, computerized device about the
size of a deck of cards that continuously delivers
small, precise amounts of insulin - for 16 years
and started using a MiniMed insulin pump with
SmartGuard technology two years ago. She
says SmartGuard technology has had a major
impact on her diabetes management.
¡°My MiniMed insulin pump with SmartGuard
technology has offered me flexibility and con-
fidence in managing my diabetes so I can just
live my life,¡± Kaplan says. ¡°Now I have greater
peace of mind.¡±
In August 2016, Medtronic introduced in the
U.S. one of its most advanced insulin pump
systems, the MiniMed 630G system, featur-
ing SmartGuard technology coupled with an
enhanced glucose sensor. The features of this
insulin pump are based on feedback from more
[1] Seaquist ER, Anderson J, Childs B, Cryer P,
Dagogo-Jack S, Fish L, Heller SR, Rodriguez H,
Rosenzweig J, Vigersky R. Hypoglycemia and
diabetes: a report of a workgroup of the American
Diabetes Association and the Endocrine Society.
Diabetes Care. 2013 May;36(5):1384-95.
[2] Bergenstal RM, Klonoff DC, Garg SK, et
al. Threshold-based insulin-pump interruption
for reduction of hypoglycemia. N Engl J Med.
2013;369(3):224-232.
*Measured as low sensor glucose events ¡Ü65 mg/
dL.
**Based upon limited sample size and duration of
ASPIRE In-Home study.
***The pump is protected against the effects of
continuous immersion in up to 12 feet (3.6 me-
ters) of water for up to 24 hours at a time at the
time of manufacture. This is classified as IPX8
rating.